Global Botanical and plant-derived drugs market Size study, by source (Plant, Algae, Macroscopic fungi) By dosage form (Pills, Tablets, Capsules, Injection) By Therapeutic applications (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases) and Regional Forecasts 2019-2026
Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Botanical drugs are derived from medicinal plants. Botanical drugs contain algae vegetable substance, and macroscopic fungi. Botanical and plant derived drugs help in treatment of various diseases, such as central nervous system disorders, infectious diseases cardiovascular diseases, and respiratory diseases. These drugs are used as an important component in medicine and therapies such as homeopathy and ayurvedic medicines. Increasing risk of side effects with the consumption of synthetic drugs such as gastrointestinal upsets, allergic reactions and more, these factors are increasing the demand for botanical and plant derived drugs. In addition, increasing incidences of chronic diseases are further contributing towards market growth. Increasing adoption of botanical and plant derived drugs in the treatment of respiratory and infectious disease is expected to create significant growth opportunity in the market over the forecast period. For instance, convallaria majalis plant extract is used in for the treatment of cardiovascular disease. Mytesi is a botanical drug approved for the symptom’s relief on noninfectious diarrhea in adults with HIV/AIDS. Also, introduction of medicines made from plants for the treatment of cardiac such as acetyldigoxin, adoniside are also rising adoption of botanical and plant derived drugs. However, stringent laws and regulations for approval of botanical drugs impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Botanical and plant-derived drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high adoption of herbal drugs and technological advances. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing awareness towards botanical and plant derived drugs and increasing prevalence of chronic diseases would create lucrative growth prospects for the Botanical and plant-derived drugs market across Asia-Pacific region.
Major market player included in this report are:
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By source:
Plant
Algae
Macroscopic fungi
By dosage form:
Pills
Tablets
Capsules
Injection
By Therapeutic applications:
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Botanical and plant-derived drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Botanical and plant-derived drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high adoption of herbal drugs and technological advances. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing awareness towards botanical and plant derived drugs and increasing prevalence of chronic diseases would create lucrative growth prospects for the Botanical and plant-derived drugs market across Asia-Pacific region.
Major market player included in this report are:
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By source:
Plant
Algae
Macroscopic fungi
By dosage form:
Pills
Tablets
Capsules
Injection
By Therapeutic applications:
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Botanical and plant-derived drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Botanical and plant-derived drugs Market, by Region, 2017-2026 (USD Billion)
1.2.2. Botanical and plant-derived drugs Market, by source, 2017-2026 (USD Billion)
1.2.3. Botanical and plant-derived drugs Market, by dosage form, 2017-2026 (USD Billion)
1.2.4. Botanical and plant-derived drugs Market, by Therapeutic application, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET DYNAMICS
3.1. Botanical and plant-derived drugs Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY SOURCE
5.1. Market Snapshot
5.2. Global Botanical and plant-derived drugs Market by source, Performance - Potential Analysis
5.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by By source 2016-2026 (USD Billion)
5.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
5.4.1. Plant
5.4.2. Algae
5.4.3. Macroscopic fungi
CHAPTER 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY DOSAGE FORM
6.1. Market Snapshot
6.2. Global Botanical and plant-derived drugs Market by dosage form, Performance - Potential Analysis
6.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
6.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
6.4.1. Pills
6.4.2. Tablets
6.4.3. Capsules
6.4.4. Injection
CHAPTER 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY THERAPEUTIC APPLICATIONS
7.1. Market Snapshot
7.2. Global Botanical and plant-derived drugs Market by therapeutic application, Performance - Potential Analysis
7.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
7.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
7.4.1. Central Nervous System
7.4.2. Cardiovascular Diseases
7.4.3. Infectious Diseases
7.4.4. Respiratory Diseases
CHAPTER 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REGIONAL ANALYSIS
8.1. Botanical and plant-derived drugs Market, Regional Market Snapshot
8.2. North America Botanical and plant-derived drugs Market
8.2.1. U.S. Botanical and plant-derived drugs Market
8.2.1.1. Source breakdown estimates & forecasts, 2016-2026
8.2.1.2. Dosage form breakdown estimates & forecasts, 2016-2026
8.2.1.3. Therapeutic application breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Botanical and plant-derived drugs Market
8.3. Europe Botanical and plant-derived drugs Market Snapshot
8.3.1. U.K. Botanical and plant-derived drugs Market
8.3.2. Rest of Europe Botanical and plant-derived drugs Market
8.4. Asia-Pacific Botanical and plant-derived drugs Market Snapshot
8.4.1. China Botanical and plant-derived drugs Market
8.4.2. India Botanical and plant-derived drugs Market
8.4.3. Japan Botanical and plant-derived drugs Market
8.4.4. Rest of Asia Pacific Botanical and plant-derived drugs Market
8.5. Latin America Botanical and plant-derived drugs Market Snapshot
8.5.1. Brazil Botanical and plant-derived drugs Market
8.5.2. Mexico Botanical and plant-derived drugs Market
8.6. Rest of The World Botanical and plant-derived drugs Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bayer Healthcare LLC
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abott Laboratories
9.2.3. GlaxoSmithKline plc
9.2.4. Pfizer Inc, Sanofi
9.2.5. Actelion Pharmaceuticals Ltd
9.2.6. Aimil Pharmaceuticals India Ltd
9.2.7. Boehringer Ingelheim GmbH
9.2.8. Bristol-Myers Squibb Company
9.2.9. Concordia Pharmaceuticals Inc.
9.2.10. GW Pharmaceuticals plc
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Botanical and plant-derived drugs Market, by Region, 2017-2026 (USD Billion)
1.2.2. Botanical and plant-derived drugs Market, by source, 2017-2026 (USD Billion)
1.2.3. Botanical and plant-derived drugs Market, by dosage form, 2017-2026 (USD Billion)
1.2.4. Botanical and plant-derived drugs Market, by Therapeutic application, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET DYNAMICS
3.1. Botanical and plant-derived drugs Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY SOURCE
5.1. Market Snapshot
5.2. Global Botanical and plant-derived drugs Market by source, Performance - Potential Analysis
5.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by By source 2016-2026 (USD Billion)
5.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
5.4.1. Plant
5.4.2. Algae
5.4.3. Macroscopic fungi
CHAPTER 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY DOSAGE FORM
6.1. Market Snapshot
6.2. Global Botanical and plant-derived drugs Market by dosage form, Performance - Potential Analysis
6.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
6.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
6.4.1. Pills
6.4.2. Tablets
6.4.3. Capsules
6.4.4. Injection
CHAPTER 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, BY THERAPEUTIC APPLICATIONS
7.1. Market Snapshot
7.2. Global Botanical and plant-derived drugs Market by therapeutic application, Performance - Potential Analysis
7.3. Global Botanical and plant-derived drugs Market Estimates & Forecasts by dosage form 2016-2026 (USD Billion)
7.4. Botanical and plant-derived drugs Market, Sub Segment Analysis
7.4.1. Central Nervous System
7.4.2. Cardiovascular Diseases
7.4.3. Infectious Diseases
7.4.4. Respiratory Diseases
CHAPTER 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REGIONAL ANALYSIS
8.1. Botanical and plant-derived drugs Market, Regional Market Snapshot
8.2. North America Botanical and plant-derived drugs Market
8.2.1. U.S. Botanical and plant-derived drugs Market
8.2.1.1. Source breakdown estimates & forecasts, 2016-2026
8.2.1.2. Dosage form breakdown estimates & forecasts, 2016-2026
8.2.1.3. Therapeutic application breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Botanical and plant-derived drugs Market
8.3. Europe Botanical and plant-derived drugs Market Snapshot
8.3.1. U.K. Botanical and plant-derived drugs Market
8.3.2. Rest of Europe Botanical and plant-derived drugs Market
8.4. Asia-Pacific Botanical and plant-derived drugs Market Snapshot
8.4.1. China Botanical and plant-derived drugs Market
8.4.2. India Botanical and plant-derived drugs Market
8.4.3. Japan Botanical and plant-derived drugs Market
8.4.4. Rest of Asia Pacific Botanical and plant-derived drugs Market
8.5. Latin America Botanical and plant-derived drugs Market Snapshot
8.5.1. Brazil Botanical and plant-derived drugs Market
8.5.2. Mexico Botanical and plant-derived drugs Market
8.6. Rest of The World Botanical and plant-derived drugs Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bayer Healthcare LLC
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abott Laboratories
9.2.3. GlaxoSmithKline plc
9.2.4. Pfizer Inc, Sanofi
9.2.5. Actelion Pharmaceuticals Ltd
9.2.6. Aimil Pharmaceuticals India Ltd
9.2.7. Boehringer Ingelheim GmbH
9.2.8. Bristol-Myers Squibb Company
9.2.9. Concordia Pharmaceuticals Inc.
9.2.10. GW Pharmaceuticals plc
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
TABLE 3. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY BY SOURCE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET
TABLE 3. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY BY SOURCE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW BOTANICAL AND PLANT-DERIVED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
LIST OF FIGURES
FIG 1. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, KEY TRENDS 2018
FIG 5. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
COMPANIES MENTIONED
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc
FIG 1. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, KEY TRENDS 2018
FIG 5. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL BOTANICAL AND PLANT-DERIVED DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
COMPANIES MENTIONED
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc
